Overview
Two arm parallel randomized clinical trial
Description
Patients will be randomized 1:1 to receive mobile technology intervention versus usual care. Half of patients from a clinician team will receive the intervention and half will receive usual care. We aim to recruit at least 200 patients, 100 in each arm.
Eligibility
Inclusion Criteria:
- Age 30-90 yrs.
- Smartphone ownership
- Office SBP: ≥ 140 mm Hg
- ≤ 2 current anti-HTN meds
- Able to add or dose-increase at least 2 of the following classes of medications: ACE-I/ARB, diuretic, calcium channel blocker, beta-blocker, mineralocorticoid receptor antagonists (i.e., at least 2 classes are available for addition or dose- increases after excluding intolerant medications and medications currently at maximum dose)
- English or Spanish-speakers
Exclusion Criteria:
- Heart failure with reduced ejection fraction (EF < 40%)
- ESRD (GFR <15)
- Renal replacement therapy
- Pregnant
- Myocardial infarction or stroke within preceding 6 months
- Hospitalization for hypertensive emergency or malignant hypertension within preceding 6 months
- Prior solid organ transplantation
- At the clinical discretion of the investigators
- Enrolled in another clinical study